The wolframin His611Arg polymorphism influences medication overuse headache

被引:30
作者
Di Lorenzo, C. [1 ]
Sances, G.
Di Lorenzo, G.
Rengo, C.
Ghiotto, N.
Guaschino, E.
Perrotta, A.
Santorelli, F. M.
Grieco, G. S.
Troisi, A.
Siracusano, A.
Pierelli, F.
Nappi, G.
Casali, C.
机构
[1] Univ La Sapienza, UCADH, Dept Neurol & ORL, Latina, Italy
[2] IRCCS, C Mondino Inst Neurol Fdn, UCADH, Headache Unit, Pavia, Italy
[3] Univ Roma Tor Vergata, Dept Neurosci, Psychiat Clin, Rome, Italy
[4] IRCCS San Raffaele, C Mondino Inst Neurol Fdn, Mol Genet Lab, Rome, Italy
[5] IRCCS Bambino Gesu, Rome, Italy
关键词
wolframin; genetic polymorphisms; secondary headache disorder; drug overuse; addictive behaviour;
D O I
10.1016/j.neulet.2007.07.037
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Homozygosis for wolframin (WFS1) mutations determines Wolfram syndrome (WS), and common polymorphisms of WFS1 are associated with psychiatric illnesses and dependence behaviour. To test the influence of WFS1 polymorphisms on medication overuse headache (MOH), a chronic headache condition related to symptomatic drugs overuse, we analyzed 82 MOH patients for the WFS1 His61 lArg polymorphism, and performed a comparison between clinical features of Arg/Arg (R/R) and non-R/R individuals. Individuals harbouring the R/R genotype showed significantly higher monthly drug consumption (t= -3.504; p =0.00075) and more severe depressive symptoms on the BDI questionnaire -3.048; p = 0.003) than non-R/R. WFS1 polymorphism emerged as the only significant predictor of drug consumption, at the multivariate, regression analysis (F = 12.277; d.f. = 1,80; p = 0.00075, adjusted R-2 = 0.122). These results implicate WFS1 in the clinical picture of MOH, may be through an influence on need for drugs as in other conditions of abuse behaviour. (C) 2007 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:179 / 184
页数:6
相关论文
共 36 条
  • [1] Measurement of impulsivity in a hierarchical model of personality traits: Implications for substance use
    Acton, GS
    [J]. SUBSTANCE USE & MISUSE, 2003, 38 (01) : 67 - 83
  • [2] JUVENILE ONSET DIABETES-MELLITUS, CENTRAL DIABETES-INSIPIDUS AND OPTIC ATROPHY (WOLFRAM SYNDROME) - NEUROLOGICAL FINDINGS AND PROGNOSTIC IMPLICATIONS
    ALDENHOVEL, HBG
    GALLENKAMP, U
    SULEMANA, CA
    [J]. NEUROPEDIATRICS, 1991, 22 (02) : 103 - 106
  • [3] American Psychiatric Association, 2001, Diagnostic and statistical manual of mental disorders, V4th
  • [4] Beck A. T., 1996, Manual for the Beck Depression Inventory. Psychological corporation
  • [5] Endogenous opiates and behavior: 2005
    Bodnar, Richard J.
    Klein, Gad E.
    [J]. PEPTIDES, 2006, 27 (12) : 3391 - 3478
  • [6] Medication-overuse headache: similarities with drug addiction
    Calabresi, P
    Cupini, LM
    [J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 2005, 26 (02) : 62 - 68
  • [7] Personality and eating disorders: A decade in review
    Cassin, SE
    von Ranson, KM
    [J]. CLINICAL PSYCHOLOGY REVIEW, 2005, 25 (07) : 895 - 916
  • [8] Mutational spectrum of the WFS1 gene in Wolfram syndrome, nonsyndromic hearing impairment, diabetes mellitus, and psychiatric disease
    Cryns, K
    Sivakumaran, TA
    Van den Ouweland, JMW
    Pennings, RJE
    Cremers, CWRJ
    Flothmann, K
    Young, TL
    Smith, RJH
    Lesperance, MM
    Van Camp, G
    [J]. HUMAN MUTATION, 2003, 22 (04) : 275 - 287
  • [9] Does medication overuse headache represent a behavior of dependence?
    Fuh, JL
    Wang, SJ
    Lu, SR
    Juang, KD
    [J]. PAIN, 2005, 119 (1-3) : 49 - 55
  • [10] A rare coding variant within the wolframin gene in bipolar and unipolar affective disorder cases
    Furlong, RA
    Ho, LW
    Rubinsztein, JS
    Michael, A
    Walsh, C
    Paykel, ES
    Rubinsztein, DC
    [J]. NEUROSCIENCE LETTERS, 1999, 277 (02) : 123 - 126